Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

NCT00161668 | Completed

• 1 other identifier: 0903X-100847
• Study Type: observational
• Target: 500
• Locations: 1 country
• Sites: 59

Brief Summary

This study is designed to assess the safety of Mylotarg therapy in routine practice.

Conditions

Acute Myeloid Leukemia

Keywords

Leukemia

Interventions

Mylotarg DRUG

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Treated by Mylotarg
• Provide ICF

Sponsors & Collaborators

• Wyeth is now a wholly owned subsidiary of Pfizer: lead

Study Sites (59)

Unknown Facility

Tucson, Arizona, 85404, United States

Location

Unknown Facility

Berkely, California, 94704, United States

Location

Unknown Facility

Burbank, California, 91505, United States

Location

Unknown Facility

Concord, California, 94520, United States

Location

Unknown Facility

Loma Linda, California, 92354, United States

Location

Unknown Facility

Los Angeles, California, 90095-1678, United States

Location

Unknown Facility

San Francisco, California, 94143, United States

Location

Unknown Facility

Sylmar, California, 91342, United States

Location

Unknown Facility

Denver, Colorado, 80218, United States

Location

Unknown Facility

Boynton Beach, Florida, 33435, United States

Location

Unknown Facility

Plantation, Florida, 33324, United States

Location

Unknown Facility

Stuart, Florida, 34994, United States

Location

Unknown Facility

Tamarac, Florida, 33321, United States

Location

Unknown Facility

Chicago, Illinois, 60611, United States

Location

Unknown Facility

Chicago, Illinois, 60612-3838, United States

Location

Unknown Facility

Chicago, Illinois, 60612-7323, United States

Location

Unknown Facility

Chicago, Illinois, 60637, United States

Location

Unknown Facility

Indianapolis, Indiana, 46202, United States

Location

Unknown Facility

Iowa City, Iowa, 52242, United States

Location

Unknown Facility

Lexington, Kentucky, 40536-0093, United States

Location

Unknown Facility

Louisville, Kentucky, 40202, United States

Location

Unknown Facility

Shrevport, Louisiana, 71130-3932, United States

Location

Unknown Facility

Ann Arbor, Michigan, 48109-0999, United States

Location

Unknown Facility

Grand Rapids, Michigan, 49503, United States

Location

Unknown Facility

Kalamazoo, Michigan, 49007-3731, United States

Location

Unknown Facility

Kalamazoo, Michigan, 49048, United States

Location

Unknown Facility

Columbia, Missouri, 65203, United States

Location

Unknown Facility

St Louis, Missouri, 63141, United States

Location

Unknown Facility

Neptune City, New Jersey, 07754, United States

Location

Unknown Facility

Albuquerque, New Mexico, 87109, United States

Location

Unknown Facility

Buffalo, New York, 14263, United States

Location

Unknown Facility

New Hyde Park, New York, 11040, United States

Location

Unknown Facility

New York, New York, 10019, United States

Location

Unknown Facility

New York, New York, 10032, United States

Location

Unknown Facility

The Bronx, New York, 10466, United States

Location

Unknown Facility

Valhalla, New York, 10595, United States

Location

Unknown Facility

Durham, North Carolina, 27705, United States

Location

Unknown Facility

Winston-Salem, North Carolina, 27106, United States

Location

Unknown Facility

Bismarck, North Dakota, 58501, United States

Location

Unknown Facility

Akron, Ohio, 44302, United States

Location

Unknown Facility

Canton, Ohio, 44718, United States

Location

Unknown Facility

Cincinnati, Ohio, 45236, United States

Location

Unknown Facility

Cleveland, Ohio, 44195, United States

Location

Unknown Facility

Oklahoma City, Oklahoma, 72112, United States

Location

Unknown Facility

Portland, Oregon, 97201, United States

Location

Unknown Facility

Hershey, Pennsylvania, 17033-0850, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19104, United States

Location

Unknown Facility

Philadelphia, Pennsylvania, 19107, United States

Location

Unknown Facility

Pittsburgh, Pennsylvania, 15224, United States

Location

Unknown Facility

Memphis, Tennessee, 38120, United States

Location

Unknown Facility

Nashville, Tennessee, 37205, United States

Location

Unknown Facility

Nashville, Tennessee, 37232-5505, United States

Location

Unknown Facility

Houston, Texas, 77030, United States

Location

Unknown Facility

Temple, Texas, 76508, United States

Location

Unknown Facility

Arlington, Virginia, 22205, United States

Location

Unknown Facility

Richmond, Virginia, 23298-0157, United States

Location

Unknown Facility

Charleston, West Virginia, 25304, United States

Location

Unknown Facility

Morgantown, West Virginia, 26506-9162, United States

Location

Unknown Facility

Appleton, Wisconsin, 54911, United States

Location

MeSH Terms

Conditions

Leukemia, Myeloid, Acute; Leukemia

Interventions

Gemtuzumab

Condition Hierarchy (Ancestors)

Leukemia, Myeloid; Neoplasms by Histologic Type; Neoplasms; Hematologic Diseases; Hemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Calicheamicins; Aminoglycosides; Glycosides; Carbohydrates; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal; Antibodies; Immunoglobulins; Immunoproteins; Blood Proteins; Proteins; Amino Acids, Peptides, and Proteins; Serum Globulins; Globulins

Study Officials

• Medical Monitor

  Wyeth is now a wholly owned subsidiary of Pfizer

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: DEFINED POPULATION
• Time Perspective: PROSPECTIVE
• Sponsor Type: INDUSTRY

Study Record Dates

• First Submitted: September 8, 2005
• First Posted: September 12, 2005
• Study Start: October 1, 2001
• Last Updated: March 15, 2007

Record last verified: 2007-03

Locations

US (59)